Anti-TPO prevalence was significantly increased in PCOS women (OR 2.03, 95% CI: [1.35–3.04], p = 0.0006), similarly to anti-TPO level (SMD 0.63, 95% CI: [0.37–0.88], p < 0.00001). The gene discussed is TPO; the disease is polycystic ovary syndrome.